ITGB4 and triple-negative breast carcinoma: One of the molecular mechanisms proposed for this resistance in mesenchymal-like triple-negative breast cancer cells is due to the expression of ITGB4 + in intermediate states, regulated by Zeb1 through its repression on Tap63α expression, a protein that promotes ITGB4 expression (Bierie et al. 2017).